An enzyme-linked immunosorbent assay (ELISA) was calibrated and used for quantitation of the folate binding protein in human cerebrospinal fluid. The precision of the assay in terms of the coefficient of variation was 6.3% intra-assay (10 replicate single determinations) and 4.8% inter-assay (8 duplicate determinations). The concentration of folate binding protein in cerebrospinal fluid specimens from 20 patients with no complaints or diseases of neurological type was 0 .14-0.38, 0.24 nmol FBP/I (range and median value). The gelfiltration profiles of radioligand bound and immunoreactive folate binding protein were identical, both consisting of one major peak (M, '" 25000) and one minor peak (M, '" 1 00000).
Introduction
High-affinity folate binding proteins (FBPs) are present in milk, serum, leukocytes, and various tissues (1, 2) . The biological function of these binders are obscure, but they may serve as transport or storage proteins for folate (1) . We ha\"e pre\·iously shown (3) that human cerebrospinal fluid (CSF) contains a highaffinity FBP which resembles FBPs in other biological fluids as to ligand affinity (10 10 l/mol) and relative molecular mass (M r ' " 25000). The concentration of FBP in CSF was 0.3 nmolll expressed as maximum folate bound per I as determined by radioligand binding in equilibrium dialysis experiments (3).
We have recently developed a two-site enzyme-linked immunosorbent assay (ELISA) for quantitation of II To whom correspondence should be addressed.
human FPBs (4) . The present communication describes the use of this assay for quantitation of FBP in CSF from patients with no complaints or diseases of neurological type. Further, the relative molecular masses of radioligand bound and immunoreactive CSF FBP were compared in gelfiltration experiments.
Materials and Methods

Radioligand binding method
The binding of [3H]-folate WH]-pteroylglutamate with a specific activity of 35 -55 Ci l mmol supplied by Amersham International Ltd., Amersham , UK) to aliquots (1000 1-1-1) of a pool of human CSF was determined in equilibrium dialysis experiments (37 D C, pH 7.4) as previously described (3) .
ELISA for FBP in CSF
We used a previously described two-site enzymelinked immunosorbent assay (ELISA) for quantitation of FBP in CSF employing rabbit antibodies against low molecular weight FBP from human milk (4) . CSF was collected in conjunction with spinal anaesthesia of 20 patients who underwent surgery. Neither of these patients had complaints or diseases of neurological type. The CSF samples were kept at -20 D C until analysed.
Gelfiltration of CSF
The molecular size of FBP was estimated by chromatography on a column (5.3 cm 2 x 94 cm) of UItrogel® AcA 44 (LKB) as previously described (3) . A pool of human CSF (concentrated 10-fold on an Amicon Micro ultra filtration system 8 MC with filter PM 10, cutoff MW 10000) was incubated (3 h, 25°C) in the presence of 10 nmol/l [3H]-folate prior to column application. The column was eluted with 0.17 mol/I Tris buffer (pH 7.4) containing 1 gi l Triton X-100 and calibrated as previously described (3). The albumin concentration was monitored by an immuno turbidimetric method (Dakopatts Application Note 1986) on Cobas Fara (Roche). Antibody against human albumin was supplied by Dakopatts, Copenhagen. Radioactivity measurements on effluent fractions were performed as previously described (3). Immunoreactive FBP in the effluent fractions was determined by the above-described ELISA technique (4) .
Results
ELISA for quantitation of FBP in CSF
The above described ELISA (4) was used for quantitation of FBP in CSF. Figure 1 shows typical doseresponse curves in the ELISA after serial (two-fold) dilution of CSF samples. A pool of CSF was used for calibration of the ELISA (Fig. 1) ; the FBP concentration in the undiluted calibrator was 0.45 nmol/l as determined by radioligand binding in equilibrium dialysis experiments (reference method).
The intra-assay coefficient of variation (CV%) was 6.3% based on 10 replicate (single) determinations of the FBP concentration in a pool of CSF (0 .26 nmol FBP/I). The inter·-assay CV% was 4.8% as determined in aliquots of a pool in CSF stored at -20°C over a period of 30 weeks (8 duplicate determinations, FBP concentration 0.38 nmol/l). was performed by the present ELISA method in serially (two-fold) diluted samples (final dilution 16-fold). The median value was 0.24 nmol /l and the range 0.14-0.38 nmol/I.
Molecular size of FBP in CSF
The relative molecular mass of FBP in CSF was estimated by gelfiltration. CSF was pre-exposed to an excess of [3H]-folate prior to Ultrogel@ AcA 44 gel chromatography. As shown in Figure 2 the elution profiles of immunoreactive FBP as determined by ELISA, and radioligand bound FBP seemed to be identical, both containing a major peak at a position of 300 ml (M, . 25000) and a minor peak at a position of 230 ml (Mf ~ 100000). 
Discussion
We have recently developed an immunochemical technique. ELISA, for quantitation of human FBPs. This assay has been standardized to be used for quantitation of FBP in CSF. The method is applicable to small sample volumes which makes it particularly suitable for analysis of CSF specimens. The clinical significance of FBP determinations in human CSF still remains to be clarified.
Furthermore, our gelfiltration studies have revealed that CSF in addition to the prevailing FBP (M r ~ 25000) contains small amounts of FBP with a larger molecular size (M r ~ 100000). The concentration of FBP in CSF was of the same order of magnitude as that in serum. As discussed in our previous report (3) , this seems to indicate either that the bloodbrain barrier possesses a particularly high permeability to FBP, or that FBP is synthesized within the CNS. The fact that serum FBP shows almost no crossreactivity in the present ELISA (3) supports the latter hypothesis. In this context it is noteworthy that mammalian choroid plexus contains a membrane-associated FPB probably involved in the transfer of folates between blood and CSF (5 -8) . The protein has a relative molecular mass of 45 -60 000, but part of the folate binding activity in choroid plexus was associ-233 ated with a protein of a smaller relative molecular mass (M r ~ 20000), possibly a split product of the large binder (6, 8) .
